Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Vishnu Sureshkumar
Eligibility
Inclusion criteria
Inclusion criteria: Retrospective data of patients 18 years of age or older diagnosed with metastatic adenocarcinoma stomach
Exclusion criteria
Exclusion criteria: Chronic illness like chronic kidney disease undergoing dialysis Chronic liver disease Cardiac failure Those having secondary malignancies,autoimmune disorders,inflammatory diseases,hematological disorders and active infections Histology other than adenocarcinoma Patients with incomplete data in retrospective cohort
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the prognostic accuracy of Hemoglobin, Albumin, Lymphocyte Platelet (HALP) score in predicting overall survival in metastatic gastric cancer patients.Timepoint: 2 YEARS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To determine the predictive accuracy of Neutrophil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR), and prognostic nutritional index (PNI) individually for overall survival in patients with metastatic gastric cancer. 2.To assess the association of Hemoglobin, Albumin, Lymphocyte Platelet (HALP) score with patient and tumor characteristics like age, sex, ECOG status, comorbidities, surgeries performed tumour pathology, tumour differentiation and location in patients with metastatic gastric cancer.Timepoint: 2 YEARS | — |
Countries
India
Contacts
Public ContactDR A Anandhi
Jawaharlal Institute of Postgraduate Medical Education And Research
Outcome results
None listed